Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
about
Sertraline versus other antidepressive agents for depressionSertraline versus other antidepressive agents for depressionThe effects of financial incentives for case finding for depression in patients with diabetes and coronary heart disease: interrupted time series analysisEvidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.Screening older people with musculoskeletal pain for depressive symptoms in primary care.Coexisting anxiety disorders alter associations with physical disorders in the elderly: A Taiwan cross-sectional nationwide study.Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders.Evaluation of nurses' perceptions of the impact of targeted depression education and a screening and referral tool in an acute cardiac setting.Impact of Mental Disorders on the Association Between Adherence to Antihypertensive Agents and All-Cause Healthcare Costs.Outcome of treatment with antidepressants in patients with hypertension and undetected depression.The effect of educational audiotape programme on anxiety and depression in patients undergoing coronary artery bypass graft.Effect of alprazolam on anxiety and cardiomyopathy induced by doxorubicin in mice.Identifying depression in patients following admission for acute coronary syndrome.Effectiveness of psychological interventions to improve quality of life in people with long-term conditions: rapid systematic review of randomised controlled trials.
P2860
Q24235928-1A3CB88B-18DC-4B42-87CA-320B717A1A6FQ24241023-F5FDB64F-0C80-44ED-8A90-422E869C0CB2Q34071866-F6FF8419-E885-41CB-9C8E-975737898E6BQ34465555-4FCD9F60-ECF2-46BE-A674-7F4C3E9854D9Q36909210-3BD6FB6D-D629-4E9A-A899-5734A2824182Q40917213-E3962BEB-8EEA-4915-AB99-C87013C01CB4Q42326287-73E0E608-21F4-4B61-A739-902A1AE95473Q46165722-267A3AD0-3220-4D5B-BBB5-8F5D95DA53AEQ47989093-A511E0D3-BBE5-4D1F-8894-7959AEC3113BQ48241646-DEE663E4-F896-4CA2-BB91-7CAE1ECDB707Q48504773-FF4EEE6F-8F4D-4DA4-ADD8-3BCBD2AC78FEQ50641596-EC2B64B4-C130-4D73-AF87-9A901175EC9BQ50903890-99AF23AC-7DFA-4E38-84F5-BB8EFCCA3271Q55400606-87195FB9-2286-4607-B8A2-1F035ADECAF0
P2860
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@ast
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@en
type
label
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@ast
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@en
prefLabel
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@ast
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@en
P2093
P2860
P356
P1433
P1476
Treatment of anxiety and depressive disorders in patients with cardiovascular disease.
@en
P2093
John Potokar
Peter R Jackson
Simon J C Davies
P2860
P304
P356
10.1136/BMJ.328.7445.939
P407
P50
P577
2004-04-01T00:00:00Z